首页 > 最新文献

Auris Nasus Larynx最新文献

英文 中文
Clinical and pathological characteristics of CRS with nasal polyps in patients with asthma–COPD overlap 哮喘-慢性阻塞性肺病重叠患者CRS合并鼻息肉的临床和病理特征
IF 1.5 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-10-23 DOI: 10.1016/j.anl.2025.10.007
Masayoshi Mukai , Haruka Nakanishi , Kanako Matsui , Emiri Sato , Manabu Nonaka , Naoko Yanagisawa

Objective

Bronchial asthma (BA) and Chronic Obstructive Pulmonary Disease (COPD) have been considered as independent diseases, but in recent years, Asthma and COPD Overlap (ACO), which combines characteristics of BA and COPD, has been defined. Chronic rhinosinusitis (CRS) with nasal polyps and BA, both caused by similar type 2 inflammation, often coexist and are considered to have a “one airway, one disease” relationship. In ACO, airway inflammatory cells of BA (eosinophils and CD4+ lymphocytes) and COPD (neutrophils, CD8+ lymphocytes and macrophages) coincide, theoretically leading to steroid resistance compared to BA alone. Based on the “one airway, one disease” concept, we hypothesized that clinical and pathological characteristics of CRS differs depending on its comorbidity with ACO or with BA alone.

Methods

Sixty-two CRS patients with BA who underwent endoscopic surgery for CRS with nasal polyp at our hospital between January 2014 and December 2022 were included in this study, and were followed at our hospital until December 2023. The patients were categorized by pulmonologists into 21 patients of CRS-ACO and 41 patients of CRS-BA according to the Japanese guidelines for the Management of ACO 2018. We compared recurrence-free period of nasal polyps between these two groups. Nasal polyps from CRS-ACO (n = 11) and CRS-BA (n = 13) those who consented to this study were subjected to histologic examination and the numbers of eosinophils, and cell positive for CD4, CD8, elastase (a marker for neutrophils), and CD163 (a marker for macrophages) were counted.

Results

CRS-ACO had a significantly faster recurrence time, compared to the recurrence time in CRS-BA, and was a risk factor for recurrence. Nasal polyps from CRS-ACO and CRS-BA those who consented to this study were subjected to histologic examination. Elastase, CD8, and CD163 positive cell numbers were significantly higher in CRS-ACO than in CRS-BA patients.

Conclusion

CRS-ACO patients were prone to recurrence of nasal polyps, and the pathology of nasal polyps in CRS-ACO patients were significantly infiltrated with neutrophilic inflammatory cells. CRS-ACO patients revealed inflammatory cell infiltration in the upper airway (nasal polyps) and similar cell types was confirmed to coexist in the lower airway, suggests the possibility of a “one airway, one disease” concept, not only in BA, but also in ACO as well.
目的支气管哮喘(BA)和慢性阻塞性肺疾病(COPD)一直被认为是独立的疾病,但近年来,结合BA和COPD特征的哮喘和COPD重叠(ACO)被定义。慢性鼻鼻窦炎(CRS)合并鼻息肉和BA,两者都是由相似的2型炎症引起的,经常共存,被认为是“一种气道,一种疾病”的关系。在ACO中,BA(嗜酸性粒细胞和CD4+淋巴细胞)和COPD(中性粒细胞、CD8+淋巴细胞和巨噬细胞)的气道炎症细胞重合,理论上导致与BA单独相比的类固醇耐药。基于“一种气道,一种疾病”的概念,我们假设CRS的临床和病理特征因其与ACO合并症或单独与BA合并症而不同。方法选取2014年1月至2022年12月在我院行CRS合并鼻息肉内镜手术治疗的62例CRS合并BA患者,随访至2023年12月。肺科医生根据日本2018年ACO管理指南将患者分为21例CRS-ACO患者和41例CRS-BA患者。比较两组鼻息肉无复发时间。同意本研究的CRS-ACO (n = 11)和CRS-BA (n = 13)鼻息肉患者接受组织学检查,计数嗜酸性粒细胞数量,CD4、CD8、弹性蛋白酶(中性粒细胞标记物)和CD163(巨噬细胞标记物)阳性细胞数量。结果scrs - aco的复发时间明显快于CRS-BA的复发时间,是复发的危险因素。接受CRS-ACO和CRS-BA组鼻息肉患者进行组织学检查。CRS-ACO患者的Elastase、CD8和CD163阳性细胞数明显高于CRS-BA患者。结论CRS-ACO患者鼻息肉易复发,且CRS-ACO患者鼻息肉病理明显浸润中性粒细胞炎性细胞。CRS-ACO患者在上气道发现炎症细胞浸润(鼻息肉),下气道也发现类似的细胞类型共存,提示“一种气道,一种疾病”概念的可能性,不仅在BA中,在ACO中也是如此。
{"title":"Clinical and pathological characteristics of CRS with nasal polyps in patients with asthma–COPD overlap","authors":"Masayoshi Mukai ,&nbsp;Haruka Nakanishi ,&nbsp;Kanako Matsui ,&nbsp;Emiri Sato ,&nbsp;Manabu Nonaka ,&nbsp;Naoko Yanagisawa","doi":"10.1016/j.anl.2025.10.007","DOIUrl":"10.1016/j.anl.2025.10.007","url":null,"abstract":"<div><h3>Objective</h3><div>Bronchial asthma (BA) and Chronic Obstructive Pulmonary Disease (COPD) have been considered as independent diseases, but in recent years, Asthma and COPD Overlap (ACO), which combines characteristics of BA and COPD, has been defined. Chronic rhinosinusitis (CRS) with nasal polyps and BA, both caused by similar type 2 inflammation, often coexist and are considered to have a “one airway, one disease” relationship. In ACO, airway inflammatory cells of BA (eosinophils and CD4<sup>+</sup> lymphocytes) and COPD (neutrophils, CD8+ lymphocytes and macrophages) coincide, theoretically leading to steroid resistance compared to BA alone. Based on the “one airway, one disease” concept, we hypothesized that clinical and pathological characteristics of CRS differs depending on its comorbidity with ACO or with BA alone.</div></div><div><h3>Methods</h3><div>Sixty-two CRS patients with BA who underwent endoscopic surgery for CRS with nasal polyp at our hospital between January 2014 and December 2022 were included in this study, and were followed at our hospital until December 2023. The patients were categorized by pulmonologists into 21 patients of CRS-ACO and 41 patients of CRS-BA according to the Japanese guidelines for the Management of ACO 2018. We compared recurrence-free period of nasal polyps between these two groups. Nasal polyps from CRS-ACO (<em>n</em> = 11) and CRS-BA (<em>n</em> = 13) those who consented to this study were subjected to histologic examination and the numbers of eosinophils, and cell positive for CD4, CD8, elastase (a marker for neutrophils), and CD163 (a marker for macrophages) were counted.</div></div><div><h3>Results</h3><div>CRS-ACO had a significantly faster recurrence time, compared to the recurrence time in CRS-BA, and was a risk factor for recurrence. Nasal polyps from CRS-ACO and CRS-BA those who consented to this study were subjected to histologic examination. Elastase, CD8, and CD163 positive cell numbers were significantly higher in CRS-ACO than in CRS-BA patients.</div></div><div><h3>Conclusion</h3><div>CRS-ACO patients were prone to recurrence of nasal polyps, and the pathology of nasal polyps in CRS-ACO patients were significantly infiltrated with neutrophilic inflammatory cells. CRS-ACO patients revealed inflammatory cell infiltration in the upper airway (nasal polyps) and similar cell types was confirmed to coexist in the lower airway, suggests the possibility of a “one airway, one disease” concept, not only in BA, but also in ACO as well.</div></div>","PeriodicalId":55627,"journal":{"name":"Auris Nasus Larynx","volume":"52 6","pages":"Pages 744-749"},"PeriodicalIF":1.5,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145364135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of intratympanic administration of glucocorticoids on the guinea pig inner ear 鼓腔内给药糖皮质激素对豚鼠内耳的影响。
IF 1.5 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-10-22 DOI: 10.1016/j.anl.2025.09.005
Akinobu Kakigi , Makoto Kinoshita , Yuki Katsutani , Toshihito Sahara , Shinji Yamashita , Kenji Kondo

Objective

This study investigates the effects of intratympanic glucocorticoid administration on the inner ear.

Methods

Fifteen Hartley guinea pigs were used and divided into five groups: dexamethasone-treated (n = 5), contralateral dexamethasone-treated (n = 5), hydrocortisone-treated (n = 5), contralateral hydrocortisone-treated (n = 5), and control (n = 5). In the control group, 1 ml of saline was injected into the right tympanic cavity via a ventral approach. In the dexamethasone-treated group, 1 ml of dexamethasone at a concentration of 3.3 mg/ml was injected into the right tympanic cavity using the same method, while the left ear of the dexamethasone-treated group remained intact. In the hydrocortisone-treated group, 1 ml of hydrocortisone at a concentration of 50 mg/ml was injected into the right tympanic cavity using the same technique, with the left ear of the hydrocortisone-treated group also remaining intact.
To assess the effects of glucocorticoids on the inner ear, we measured a cross-sectional area analysis of the scala media at three hours post-corticosteroids treatment using optical coherence tomography (OCT). The degree of a cross-sectional area change was quantitatively measured using a video digitizer.

Results

Ears treated with either dexamethasone or hydrocortisone showed extension of Reissner's membrane and endolymphatic hydrops. Statistical analysis indicated that a cross-sectional area of the scala media increased significantly compared to the contralateral hydrocortisone-treated and control groups.

Conclusions

This is the first report to investigate the effects of intratympanic administration of glucocorticoids on the guinea pig cochlea. Dilated endolymphatic space was observed in the steroid-treated ears. Although the underlying mechanism of these histological changes remains unclear, great care must be taken when administering steroids to patients with endolymphatic hydrops-related diseases, such as Meniere's disease.
目的:探讨鼓室内给药糖皮质激素对内耳的影响。方法:选取15只Hartley豚鼠,随机分为5组:地塞米松组(n = 5)、对侧地塞米松组(n = 5)、氢化可的松组(n = 5)、对侧氢化可的松组(n = 5)和对照组(n = 5)。对照组经腹侧入路将生理盐水1 ml注入右鼓室。地塞米松治疗组,同样方法将浓度为3.3 mg/ml的地塞米松1 ml注射到右鼓室,而地塞米松治疗组的左耳保持完整。在氢化可的松处理组,使用相同的技术将浓度为50 mg/ml的氢化可的松1 ml注射到右鼓室,氢化可的松处理组的左耳也保持完整。为了评估糖皮质激素对内耳的影响,我们使用光学相干断层扫描(OCT)测量了糖皮质激素治疗后3小时scala介质的横截面积分析。横截面积变化的程度用视频数字化仪定量测量。结果:用地塞米松或氢化可的松治疗的耳部均出现雷氏膜扩张和内淋巴积液。统计分析表明,与对侧氢化可的松治疗组和对照组相比,中膜横截面积显著增加。结论:这是首次报道鼓室内给药糖皮质激素对豚鼠耳蜗的影响。类固醇治疗后耳内淋巴间隙扩大。虽然这些组织学改变的潜在机制尚不清楚,但在给患有内淋巴水肿相关疾病(如梅尼埃病)的患者使用类固醇时必须非常小心。
{"title":"Effects of intratympanic administration of glucocorticoids on the guinea pig inner ear","authors":"Akinobu Kakigi ,&nbsp;Makoto Kinoshita ,&nbsp;Yuki Katsutani ,&nbsp;Toshihito Sahara ,&nbsp;Shinji Yamashita ,&nbsp;Kenji Kondo","doi":"10.1016/j.anl.2025.09.005","DOIUrl":"10.1016/j.anl.2025.09.005","url":null,"abstract":"<div><h3>Objective</h3><div>This study investigates the effects of intratympanic glucocorticoid administration on the inner ear.</div></div><div><h3>Methods</h3><div>Fifteen Hartley guinea pigs were used and divided into five groups: dexamethasone-treated (<em>n</em> = 5), contralateral dexamethasone-treated (<em>n</em> = 5), hydrocortisone-treated (<em>n</em> = 5), contralateral hydrocortisone-treated (<em>n</em> = 5), and control (<em>n</em> = 5). In the control group, 1 ml of saline was injected into the right tympanic cavity via a ventral approach. In the dexamethasone-treated group, 1 ml of dexamethasone at a concentration of 3.3 mg/ml was injected into the right tympanic cavity using the same method, while the left ear of the dexamethasone-treated group remained intact. In the hydrocortisone-treated group, 1 ml of hydrocortisone at a concentration of 50 mg/ml was injected into the right tympanic cavity using the same technique, with the left ear of the hydrocortisone-treated group also remaining intact.</div><div>To assess the effects of glucocorticoids on the inner ear, we measured a cross-sectional area analysis of the scala media at three hours post-corticosteroids treatment using optical coherence tomography (OCT). The degree of a cross-sectional area change was quantitatively measured using a video digitizer.</div></div><div><h3>Results</h3><div>Ears treated with either dexamethasone or hydrocortisone showed extension of Reissner's membrane and endolymphatic hydrops. Statistical analysis indicated that a cross-sectional area of the scala media increased significantly compared to the contralateral hydrocortisone-treated and control groups.</div></div><div><h3>Conclusions</h3><div>This is the first report to investigate the effects of intratympanic administration of glucocorticoids on the guinea pig cochlea. Dilated endolymphatic space was observed in the steroid-treated ears. Although the underlying mechanism of these histological changes remains unclear, great care must be taken when administering steroids to patients with endolymphatic hydrops-related diseases, such as Meniere's disease.</div></div>","PeriodicalId":55627,"journal":{"name":"Auris Nasus Larynx","volume":"52 6","pages":"Pages 729-734"},"PeriodicalIF":1.5,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reconstruction of esophageal fistula induced by lenvatinib in thyroid cancer using deltopectoral flap 胸三角皮瓣重建lenvatinib致甲状腺癌食管瘘。
IF 1.5 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-10-22 DOI: 10.1016/j.anl.2025.10.005
Yuji Kanazawa , Yoshiharu Kitani , Maki Kitatsuji , Yusuke Yamamoto , Aya Matsubara , Makoto Suzuki
Lenvatinib, a multi-target tyrosine kinase inhibitor, has demonstrated efficacy in the treatment of various solid tumors, including thyroid cancer. However, life-threatening complications such as fistula formation have been observed in some cases. We report the case of a 47-year-old woman who developed an esophageal fistula following lenvatinib treatment for recurrent thyroid cancer. The patient initially underwent limited resection of the muscular layer of the cervical esophagus and preservation of the mucosa, followed by prophylactic radiotherapy because of inadequate surgical margins. Locoregional and pulmonary metastases developed 8 months postoperatively, and lenvatinib therapy was initiated at a dose of 24 mg. Subsequently, a fistula developed from the esophagus to the cervical skin. Esophageal fistula reconstruction was performed using a deltopectoral (DP) flap. Lenvatinib was resumed at a reduced dose of 14 mg two months after reconstruction. At 18 months after resuming lenvatinib, progression-free survival and adequate oral intake were achieved. The success of the DP flap reconstruction in this case highlights its potential as a durable solution for esophageal fistulas in patients receiving lenvatinib treatment. The robust blood supply provided by the DP flap may counteract the antiangiogenic effects of lenvatinib, thereby enabling continued treatment for locoregional recurrence.
Lenvatinib是一种多靶点酪氨酸激酶抑制剂,已经证明对包括甲状腺癌在内的各种实体肿瘤有疗效。然而,在一些病例中观察到危及生命的并发症,如瘘管形成。我们报告的情况下,47岁的妇女谁发展食管瘘后lenvatinib治疗复发性甲状腺癌。患者最初接受了颈部食管肌肉层的有限切除和粘膜的保留,随后由于手术切缘不足进行了预防性放疗。术后8个月出现局部和肺转移,lenvatinib治疗开始剂量为24mg。随后,从食道到颈部皮肤形成瘘管。食管瘘重建采用三角胸肌(DP)皮瓣。重建两个月后,Lenvatinib以14mg的减少剂量恢复。在恢复lenvatinib 18个月后,无进展生存期和足够的口服摄入量实现了。本例DP皮瓣重建的成功突出了其作为接受lenvatinib治疗的患者食管瘘持久解决方案的潜力。DP皮瓣提供的强大血液供应可能抵消lenvatinib的抗血管生成作用,从而使局部复发的持续治疗成为可能。
{"title":"Reconstruction of esophageal fistula induced by lenvatinib in thyroid cancer using deltopectoral flap","authors":"Yuji Kanazawa ,&nbsp;Yoshiharu Kitani ,&nbsp;Maki Kitatsuji ,&nbsp;Yusuke Yamamoto ,&nbsp;Aya Matsubara ,&nbsp;Makoto Suzuki","doi":"10.1016/j.anl.2025.10.005","DOIUrl":"10.1016/j.anl.2025.10.005","url":null,"abstract":"<div><div>Lenvatinib, a multi-target tyrosine kinase inhibitor, has demonstrated efficacy in the treatment of various solid tumors, including thyroid cancer. However, life-threatening complications such as fistula formation have been observed in some cases. We report the case of a 47-year-old woman who developed an esophageal fistula following lenvatinib treatment for recurrent thyroid cancer. The patient initially underwent limited resection of the muscular layer of the cervical esophagus and preservation of the mucosa, followed by prophylactic radiotherapy because of inadequate surgical margins. Locoregional and pulmonary metastases developed 8 months postoperatively, and lenvatinib therapy was initiated at a dose of 24 mg. Subsequently, a fistula developed from the esophagus to the cervical skin. Esophageal fistula reconstruction was performed using a deltopectoral (DP) flap. Lenvatinib was resumed at a reduced dose of 14 mg two months after reconstruction. At 18 months after resuming lenvatinib, progression-free survival and adequate oral intake were achieved. The success of the DP flap reconstruction in this case highlights its potential as a durable solution for esophageal fistulas in patients receiving lenvatinib treatment. The robust blood supply provided by the DP flap may counteract the antiangiogenic effects of lenvatinib, thereby enabling continued treatment for locoregional recurrence.</div></div>","PeriodicalId":55627,"journal":{"name":"Auris Nasus Larynx","volume":"52 6","pages":"Pages 725-728"},"PeriodicalIF":1.5,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of perioperative oral care on postoperative infections in patients with head and neck cancer: A retrospective study comparing before and during the coronavirus disease 2019 pandemic 围手术期口腔护理对头颈癌患者术后感染的影响:2019冠状病毒病大流行前后的回顾性研究
IF 1.5 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-10-22 DOI: 10.1016/j.anl.2025.10.003
Azusa Kai , Kimie Fujita , Naohisa Wada , Takashi Nakagawa

Objective

Infection prevention is crucial in head and neck cancer surgery due to the high risk of surgical site contamination by oral bacteria and pharyngeal secretions. The coronavirus disease 2019 (COVID-19) pandemic has introduced significant challenges to infection control in medical settings, including restrictions on patient care and changes to perioperative management. This study investigated the incidence of postoperative pneumonia (PP) and surgical site infection (SSI) before and during the COVID-19 pandemic, and examined how perioperative oral care and oral hygiene status were associated with the occurrence of postoperative infections.

Methods

We retrospectively reviewed the medical records of patients who underwent head and neck cancer surgery between January 2018 and March 2022. The incidences of PP and SSI were compared before and during the COVID-19 pandemic. In addition, variables identified by univariate analysis as predictors of postoperative infection were incorporated and examined using logistic regression analysis.

Results

A total of 213 patients were included in this study. The incidence rates of PP and SSI were 15.0% and 24.4%, respectively, with no statistically significant difference before and during the pandemic. The risk factors for PP included preoperative oral dryness (odds ratio [OR] = 2.65; 95% confidence interval [CI] = 1.14–6.17; p = 0.024), and diabetes (OR = 2.65; 95% CI = 1.04–6.72; p = 0.040), while for SSI, the risk factors included lack of postoperative oral care (OR = 0.29; 95% CI = 0.10–0.86; p = 0.026), prolonged operative time (OR = 1.80; 95% CI = 1.09–2.99; p = 0.022), and preoperative radiotherapy (OR = 2.25; 95% CI = 1.02–4.95; p = 0.044).

Conclusion

Appropriate perioperative oral care remains essential, even in the post-COVID-19 era. This study highlights the importance of preventing oral dryness before surgery and ensuring continuous professional oral care before and after surgery to prevent postoperative infections.
目的:口腔细菌和咽分泌物极易污染头颈部肿瘤手术部位,因此预防感染是头颈部肿瘤手术的关键。2019年冠状病毒病(COVID-19)大流行给医疗环境中的感染控制带来了重大挑战,包括对患者护理的限制和围手术期管理的改变。本研究调查了2019冠状病毒病大流行前和期间患者术后肺炎(PP)和手术部位感染(SSI)的发生率,并探讨围手术期口腔护理和口腔卫生状况与术后感染发生的关系。方法:回顾性分析2018年1月至2022年3月期间接受头颈癌手术患者的医疗记录。比较新冠肺炎大流行前后PP和SSI的发生率。此外,通过单变量分析确定的预测术后感染的变量被纳入并使用逻辑回归分析进行检验。结果:本研究共纳入213例患者。PP和SSI的发病率分别为15.0%和24.4%,大流行前和大流行期间差异无统计学意义。PP的风险因素包括术前口腔干燥(优势比[或]= 2.65;95%可信区间[CI] = 1.14 - -6.17; p = 0.024),和糖尿病(OR = 2.65; 95%可信区间-6.72 = 1.04;p = 0.040),而对于SSI,风险因素包括缺乏术后口腔护理(OR = 0.29; 95%可信区间-0.86 = 0.10;p = 0.026),延长手术时间(OR = 1.80; 95%可信区间-2.99 = 1.09;p = 0.022),和术前放疗(OR = 2.25; 95%可信区间-4.95 = 1.02;p = 0.044)。结论:即使在后covid -19时代,适当的围手术期口腔护理仍然至关重要。本研究强调了术前预防口腔干燥的重要性,并确保术前和术后持续的专业口腔护理,以防止术后感染。
{"title":"Impact of perioperative oral care on postoperative infections in patients with head and neck cancer: A retrospective study comparing before and during the coronavirus disease 2019 pandemic","authors":"Azusa Kai ,&nbsp;Kimie Fujita ,&nbsp;Naohisa Wada ,&nbsp;Takashi Nakagawa","doi":"10.1016/j.anl.2025.10.003","DOIUrl":"10.1016/j.anl.2025.10.003","url":null,"abstract":"<div><h3>Objective</h3><div>Infection prevention is crucial in head and neck cancer surgery due to the high risk of surgical site contamination by oral bacteria and pharyngeal secretions. The coronavirus disease 2019 (COVID-19) pandemic has introduced significant challenges to infection control in medical settings, including restrictions on patient care and changes to perioperative management. This study investigated the incidence of postoperative pneumonia (PP) and surgical site infection (SSI) before and during the COVID-19 pandemic, and examined how perioperative oral care and oral hygiene status were associated with the occurrence of postoperative infections.</div></div><div><h3>Methods</h3><div>We retrospectively reviewed the medical records of patients who underwent head and neck cancer surgery between January 2018 and March 2022. The incidences of PP and SSI were compared before and during the COVID-19 pandemic. In addition, variables identified by univariate analysis as predictors of postoperative infection were incorporated and examined using logistic regression analysis.</div></div><div><h3>Results</h3><div>A total of 213 patients were included in this study. The incidence rates of PP and SSI were 15.0% and 24.4%, respectively, with no statistically significant difference before and during the pandemic. The risk factors for PP included preoperative oral dryness (odds ratio [OR] = 2.65; 95% confidence interval [CI] = 1.14–6.17; <em>p</em> = 0.024), and diabetes (OR = 2.65; 95% CI = 1.04–6.72; <em>p</em> = 0.040), while for SSI, the risk factors included lack of postoperative oral care (OR = 0.29; 95% CI = 0.10–0.86; <em>p</em> = 0.026), prolonged operative time (OR = 1.80; 95% CI = 1.09–2.99; <em>p</em> = 0.022), and preoperative radiotherapy (OR = 2.25; 95% CI = 1.02–4.95; <em>p</em> = 0.044).</div></div><div><h3>Conclusion</h3><div>Appropriate perioperative oral care remains essential, even in the post-COVID-19 era. This study highlights the importance of preventing oral dryness before surgery and ensuring continuous professional oral care before and after surgery to prevent postoperative infections.</div></div>","PeriodicalId":55627,"journal":{"name":"Auris Nasus Larynx","volume":"52 6","pages":"Pages 735-743"},"PeriodicalIF":1.5,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Summary of Japanese clinical practice guidelines for head and neck cancer - 2025 update edited by the Japan Society for Head and Neck Cancer 日本头颈癌临床实践指南总结- 2025年更新由日本头颈癌协会编辑。
IF 1.5 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-10-21 DOI: 10.1016/j.anl.2025.09.004
Nobuhiro Hanai , Mizuo Ando , Hiroto Ishiki , Nobuhiro Ueda , Susumu Okano , Isaku Okamoto , Hiroyuki Ozawa , Satoshi Kano , Tomonori Kanda , Yuki Saito , Hirotaka Shinomiya , Keisuke Takanari , Toshifumi Tomioka , Hiroshi Fuseya , Yoshitaka Honma , Atsushi Motegi , Koichi Yasuda , Takeshi Kodaira , Hiroshi Kurita , Ken-ichi Nibu , Akihiro Homma
The Japanese Clinical Practice Guidelines for Head and Neck Cancer – 2025 Edition were developed to provide clear evidence-based recommendations that reflect recent advancements and evolving clinical needs in head and neck cancer care. Advances in immunotherapy, targeted therapies, surgical techniques, and genomic medicine have expanded treatment options and added new complexities. This edition offers practical, up-to-date guidance to support consistent decision making across diverse clinical scenarios. Compared with the 2022 edition, the guidelines have been substantially expanded to 63 clinical questions (CQs) across 14 categories. A new feature is the inclusion of commentary columns that address clinically important topics not suited to the CQ format, such as special patient populations, novel therapies, and rare malignancies. To reflect the growing role of precision oncology, updated recommendations for molecular-targeted treatments have been added based on specific genomic alterations, in alignment with the current approvals in Japan. While maintaining the structure of previous editions, this edition addresses the changing clinical environment while also helping to inform future discussions and directions in head and neck cancer care.
《日本头颈癌临床实践指南- 2025版》旨在提供明确的循证建议,反映头颈癌护理的最新进展和不断变化的临床需求。免疫治疗、靶向治疗、手术技术和基因组医学的进步扩大了治疗选择,也增加了新的复杂性。这个版本提供了实用的,最新的指导,以支持在不同的临床场景一致的决策。与2022年版相比,指南已大幅扩展到14个类别的63个临床问题(CQs)。一个新的特点是包括评论专栏,解决临床重要的话题,不适合CQ格式,如特殊患者群体,新疗法,和罕见的恶性肿瘤。为了反映精确肿瘤学日益增长的作用,基于特定基因组改变的分子靶向治疗的最新建议已被添加,与日本目前的批准一致。在保持以前版本的结构的同时,这个版本解决了不断变化的临床环境,同时也有助于通知头颈癌护理的未来讨论和方向。
{"title":"Summary of Japanese clinical practice guidelines for head and neck cancer - 2025 update edited by the Japan Society for Head and Neck Cancer","authors":"Nobuhiro Hanai ,&nbsp;Mizuo Ando ,&nbsp;Hiroto Ishiki ,&nbsp;Nobuhiro Ueda ,&nbsp;Susumu Okano ,&nbsp;Isaku Okamoto ,&nbsp;Hiroyuki Ozawa ,&nbsp;Satoshi Kano ,&nbsp;Tomonori Kanda ,&nbsp;Yuki Saito ,&nbsp;Hirotaka Shinomiya ,&nbsp;Keisuke Takanari ,&nbsp;Toshifumi Tomioka ,&nbsp;Hiroshi Fuseya ,&nbsp;Yoshitaka Honma ,&nbsp;Atsushi Motegi ,&nbsp;Koichi Yasuda ,&nbsp;Takeshi Kodaira ,&nbsp;Hiroshi Kurita ,&nbsp;Ken-ichi Nibu ,&nbsp;Akihiro Homma","doi":"10.1016/j.anl.2025.09.004","DOIUrl":"10.1016/j.anl.2025.09.004","url":null,"abstract":"<div><div>The Japanese Clinical Practice Guidelines for Head and Neck Cancer – 2025 Edition were developed to provide clear evidence-based recommendations that reflect recent advancements and evolving clinical needs in head and neck cancer care. Advances in immunotherapy, targeted therapies, surgical techniques, and genomic medicine have expanded treatment options and added new complexities. This edition offers practical, up-to-date guidance to support consistent decision making across diverse clinical scenarios. Compared with the 2022 edition, the guidelines have been substantially expanded to 63 clinical questions (CQs) across 14 categories. A new feature is the inclusion of commentary columns that address clinically important topics not suited to the CQ format, such as special patient populations, novel therapies, and rare malignancies. To reflect the growing role of precision oncology, updated recommendations for molecular-targeted treatments have been added based on specific genomic alterations, in alignment with the current approvals in Japan. While maintaining the structure of previous editions, this edition addresses the changing clinical environment while also helping to inform future discussions and directions in head and neck cancer care.</div></div>","PeriodicalId":55627,"journal":{"name":"Auris Nasus Larynx","volume":"52 6","pages":"Pages 709-724"},"PeriodicalIF":1.5,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145350049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative symptom-guided plug size selection in sitting position Kobayashi plug surgery for patulous eustachian tube 术中症状引导下坐位塞的大小选择小林塞术治疗扩张性咽鼓管
IF 1.5 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-10-18 DOI: 10.1016/j.anl.2025.09.007
Takeshi Oshima , Marin Yoshida , Hideshi Shindo , Hidetoshi Oshima , Ryoji Hirai

Objective

To evaluate the efficacy and safety of Kobayashi Plug Surgery (KPS) for patulous Eustachian tube (PET) performed under local anesthesia in the sitting position, using intraoperative subjective symptoms to guide plug size selection, and to investigate its effect on revision surgery rates.

Methods

This retrospective study included 61 patients (73 ears) with refractory PET who underwent KPS between December 2023 and June 2025. All procedures were performed under local anesthesia with patients in the sitting position, allowing for real-time assessment of subjective symptoms immediately after plug placement. If symptoms persisted, the plug size was increased intraoperatively. Clinical data, surgical outcomes, plug sizes, and postoperative complications were analyzed. Long-term outcomes were assessed in 29 ears with follow-up exceeding 180 days using PHI-10, Eustachian tube function tests, and revision surgery rates.

Results

Plug placement was successful in 66 of 73 ears (90.4%). Plug size adjustment during initial surgery was performed in 5 ears (7.6%) based on persistent symptoms. Among 29 ears with long-term follow-up (median: 297.5 days), the overall revision surgery rate due to upsizing was 10.3%. However, among the 41 ears that presented with subjective symptoms at the time of surgery, only 1 case (2.4%) required revision surgery during follow-up. PHI-10 scores significantly improved from a median of 30 to 10 (p < 0.001), and sonotubometry sound pressure levels increased from 85 dB to 99 dB (p < 0.005). Tympanic membrane perforation was observed in one ear (preexisting), and ventilation tube placement for otitis media with effusion was required in 4 ears (13.8%).

Conclusion

KPS under local anesthesia in the sitting position allows for intraoperative symptom-based plug size selection, which may help reduce the need for revision surgery, especially in patients with active symptoms at the time of surgery. While the overall revision rate was 10.3%, it was markedly lower (2.4%) among symptomatic cases. Although the findings should be interpreted with caution due to the small sample size and retrospective design, this technique represents a promising approach for improving surgical outcomes in patients with refractory PET.
目的评价局麻坐位下小林塞术(Kobayashi塞术)治疗扩张性咽鼓管(PET)的疗效和安全性,以术中主观症状为指导选择塞的大小,并探讨其对改型手术率的影响。方法回顾性研究包括61例(73耳)难治性PET患者,于2023年12月至2025年6月间行KPS。所有手术均在局部麻醉下进行,患者为坐位,可在置入导管后立即实时评估主观症状。如果症状持续,则术中增加塞的大小。分析临床资料、手术结果、堵头大小和术后并发症。通过pi -10、咽鼓管功能测试和翻修手术率对29只耳朵的长期预后进行评估,随访时间超过180天。结果73耳中66耳植入成功,成功率90.4%。根据持续症状,在初始手术期间对5只耳朵(7.6%)进行耳塞大小调整。在29只长期随访耳中(中位297.5天),因增大而进行翻修手术的总体比例为10.3%。然而,在手术时出现主观症状的41只耳朵中,只有1例(2.4%)在随访期间需要翻修手术。pi -10评分从中位数30分显著提高到10分(p < 0.001),声压级从85 dB提高到99 dB (p < 0.005)。1耳(既往)鼓膜穿孔,4耳(13.8%)因中耳炎积液需放置通气管。结论坐位局麻下kps术中可根据症状选择栓的大小,尤其对于术中症状活跃的患者,可减少翻修手术的需要。虽然总体修正率为10.3%,但在有症状的病例中明显较低(2.4%)。尽管由于样本量小和回顾性设计,研究结果应谨慎解释,但该技术代表了改善难治性PET患者手术结果的有希望的方法。
{"title":"Intraoperative symptom-guided plug size selection in sitting position Kobayashi plug surgery for patulous eustachian tube","authors":"Takeshi Oshima ,&nbsp;Marin Yoshida ,&nbsp;Hideshi Shindo ,&nbsp;Hidetoshi Oshima ,&nbsp;Ryoji Hirai","doi":"10.1016/j.anl.2025.09.007","DOIUrl":"10.1016/j.anl.2025.09.007","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the efficacy and safety of Kobayashi Plug Surgery (KPS) for patulous Eustachian tube (PET) performed under local anesthesia in the sitting position, using intraoperative subjective symptoms to guide plug size selection, and to investigate its effect on revision surgery rates.</div></div><div><h3>Methods</h3><div>This retrospective study included 61 patients (73 ears) with refractory PET who underwent KPS between December 2023 and June 2025. All procedures were performed under local anesthesia with patients in the sitting position, allowing for real-time assessment of subjective symptoms immediately after plug placement. If symptoms persisted, the plug size was increased intraoperatively. Clinical data, surgical outcomes, plug sizes, and postoperative complications were analyzed. Long-term outcomes were assessed in 29 ears with follow-up exceeding 180 days using PHI-10, Eustachian tube function tests, and revision surgery rates.</div></div><div><h3>Results</h3><div>Plug placement was successful in 66 of 73 ears (90.4%). Plug size adjustment during initial surgery was performed in 5 ears (7.6%) based on persistent symptoms. Among 29 ears with long-term follow-up (median: 297.5 days), the overall revision surgery rate due to upsizing was 10.3%. However, among the 41 ears that presented with subjective symptoms at the time of surgery, only 1 case (2.4%) required revision surgery during follow-up. PHI-10 scores significantly improved from a median of 30 to 10 (p &lt; 0.001), and sonotubometry sound pressure levels increased from 85 dB to 99 dB (p &lt; 0.005). Tympanic membrane perforation was observed in one ear (preexisting), and ventilation tube placement for otitis media with effusion was required in 4 ears (13.8%).</div></div><div><h3>Conclusion</h3><div>KPS under local anesthesia in the sitting position allows for intraoperative symptom-based plug size selection, which may help reduce the need for revision surgery, especially in patients with active symptoms at the time of surgery. While the overall revision rate was 10.3%, it was markedly lower (2.4%) among symptomatic cases. Although the findings should be interpreted with caution due to the small sample size and retrospective design, this technique represents a promising approach for improving surgical outcomes in patients with refractory PET.</div></div>","PeriodicalId":55627,"journal":{"name":"Auris Nasus Larynx","volume":"52 6","pages":"Pages 704-708"},"PeriodicalIF":1.5,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145326411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of hearing impairment in unilateral hearing loss: A multicenter study of standardized sound localization tests in Japan 单侧听力损失对听力损害的影响:日本标准化声音定位测试的多中心研究
IF 1.5 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-10-18 DOI: 10.1016/j.anl.2025.09.010
Takashi Ishino , Tadao Yoshida , Satoshi Iwasaki , Naoki Oishi , Yusuke Matsuda , Tetsuya Tono , Kazuma Sugahara , Hiroshi Yamazaki , Sumito Jitsukawa , Hiroshi Nakanishi , Ryosuke Kitoh , Takashi Sato , Kazuki Nishida , Takashi Oda , Rikuto Fujita , Tomohiro Kawasumi , Chie Ishikawa , Manabu Nishida , Nobuyuki Chikuie , Yuichiro Horibe , Sachio Takeno

Objective

This study had two primary objectives: first, to standardize a sound localization test across multiple facilities in Japan, and second, to use this standardized test to analyze sound localization ability in patients with unilateral hearing loss (UHL) and identify related clinical and demographic factors.

Methods

Sound localization tests were conducted at 11 facilities, enrolling 59 UHL subjects and 77 normal-hearing controls (Ctrl). The first part of the study focused on standardizing the test protocol and establishing reference ranges and cut-off values. The second part analyzed the sound localization ability in UHL patients, measured by the root mean squared (RMS) error. The association between RMS values and factors such as residual hearing, contralateral routing of signal (CROS) hearing aid use, and Hearing Handicap Inventory for Adults (HHIA) scores were analyzed.

Results

Reference ranges and cut-off values for the standardized sound localization test were successfully established. UHL subjects exhibited significantly higher RMS values (i.e., poorer localization) compared to controls. The use of CROS hearing aids did not improve performance, and the contribution of pinna-induced spectral cues was limited. Significant associations were found between RMS values and both sound presentation position and the number of audiogram frequencies with thresholds better than 40 dB and 50 dB, with the 50 dB threshold criterion being a more prominent factor. HHIA emotional and social scores were significantly associated only with age and not with sound localization performance or other audiological factors.

Conclusions

The standardized sound localization test proved to be a reliable tool for multicenter studies. Patients with UHL have significantly impaired sound localization. Residual hearing in the impaired ear, even if limited, was found to aid localization, whereas the benefits of CROS hearing aids and monaural spectral cues were negligible in our cohort. Since only age influenced the self-perceived hearing handicap (HHIA scores), it is crucial to consider restoring binaural hearing not just to improve sound localization but also to address the broader quality-of-life issues associated with UHL.
本研究有两个主要目标:第一,标准化日本多家机构的声音定位测试;第二,使用该标准化测试分析单侧听力损失(UHL)患者的声音定位能力,并确定相关的临床和人口因素。方法在11个机构进行声音定位测试,纳入59例UHL受试者和77例正常听力对照(Ctrl)。研究的第一部分侧重于标准化测试方案,建立参考范围和截止值。第二部分分析了UHL患者的声音定位能力,采用均方根误差(RMS)测量。分析RMS值与残听、对侧信号传递(crs)助听器使用和成人听力障碍量表(HHIA)评分等因素之间的关系。结果成功建立了标准化声音定位试验的参考范围和截止值。与对照组相比,UHL受试者表现出显著更高的RMS值(即较差的定位)。使用CROS助听器并没有提高听力,而且峰诱发的频谱信号的贡献有限。RMS值与声音呈现位置和阈值高于40 dB和50 dB的听力图频率数量之间存在显著关联,其中50 dB阈值标准是一个更突出的因素。HHIA情绪和社会得分仅与年龄显著相关,而与声音定位表现或其他听力学因素无关。结论标准化声音定位测试是一种可靠的多中心研究工具。UHL患者的声音定位明显受损。受损耳的残余听力,即使有限,也有助于定位,而在我们的队列中,CROS助听器和单耳频谱线索的好处可以忽略。由于只有年龄会影响自我感知的听力障碍(HHIA评分),因此考虑恢复双耳听力不仅可以改善声音定位,还可以解决与UHL相关的更广泛的生活质量问题,这一点至关重要。
{"title":"Impact of hearing impairment in unilateral hearing loss: A multicenter study of standardized sound localization tests in Japan","authors":"Takashi Ishino ,&nbsp;Tadao Yoshida ,&nbsp;Satoshi Iwasaki ,&nbsp;Naoki Oishi ,&nbsp;Yusuke Matsuda ,&nbsp;Tetsuya Tono ,&nbsp;Kazuma Sugahara ,&nbsp;Hiroshi Yamazaki ,&nbsp;Sumito Jitsukawa ,&nbsp;Hiroshi Nakanishi ,&nbsp;Ryosuke Kitoh ,&nbsp;Takashi Sato ,&nbsp;Kazuki Nishida ,&nbsp;Takashi Oda ,&nbsp;Rikuto Fujita ,&nbsp;Tomohiro Kawasumi ,&nbsp;Chie Ishikawa ,&nbsp;Manabu Nishida ,&nbsp;Nobuyuki Chikuie ,&nbsp;Yuichiro Horibe ,&nbsp;Sachio Takeno","doi":"10.1016/j.anl.2025.09.010","DOIUrl":"10.1016/j.anl.2025.09.010","url":null,"abstract":"<div><h3>Objective</h3><div>This study had two primary objectives: first, to standardize a sound localization test across multiple facilities in Japan, and second, to use this standardized test to analyze sound localization ability in patients with unilateral hearing loss (UHL) and identify related clinical and demographic factors.</div></div><div><h3>Methods</h3><div>Sound localization tests were conducted at 11 facilities, enrolling 59 UHL subjects and 77 normal-hearing controls (Ctrl). The first part of the study focused on standardizing the test protocol and establishing reference ranges and cut-off values. The second part analyzed the sound localization ability in UHL patients, measured by the root mean squared (RMS) error. The association between RMS values and factors such as residual hearing, contralateral routing of signal (CROS) hearing aid use, and Hearing Handicap Inventory for Adults (HHIA) scores were analyzed.</div></div><div><h3>Results</h3><div>Reference ranges and cut-off values for the standardized sound localization test were successfully established. UHL subjects exhibited significantly higher RMS values (i.e., poorer localization) compared to controls. The use of CROS hearing aids did not improve performance, and the contribution of pinna-induced spectral cues was limited. Significant associations were found between RMS values and both sound presentation position and the number of audiogram frequencies with thresholds better than 40 dB and 50 dB, with the 50 dB threshold criterion being a more prominent factor. HHIA emotional and social scores were significantly associated only with age and not with sound localization performance or other audiological factors.</div></div><div><h3>Conclusions</h3><div>The standardized sound localization test proved to be a reliable tool for multicenter studies. Patients with UHL have significantly impaired sound localization. Residual hearing in the impaired ear, even if limited, was found to aid localization, whereas the benefits of CROS hearing aids and monaural spectral cues were negligible in our cohort. Since only age influenced the self-perceived hearing handicap (HHIA scores), it is crucial to consider restoring binaural hearing not just to improve sound localization but also to address the broader quality-of-life issues associated with UHL.</div></div>","PeriodicalId":55627,"journal":{"name":"Auris Nasus Larynx","volume":"52 6","pages":"Pages 690-703"},"PeriodicalIF":1.5,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145326424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New method; continuous water perfusion method during endoscopic resection for the superficial pharyngeal squamous cell carcinoma 新方法;连续水灌注法在咽浅鳞癌内镜切除术中的应用。
IF 1.5 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-10-17 DOI: 10.1016/j.anl.2025.10.002
Naohiro Nakamura , Tomofumi Sakagami , Kensuke Suzuki , Takuo Fujisawa , Takuya Shijimaya , Sanshiro Kobayashi , Masataka Masuda , Yu Takahashi , Tomomitsu Tahara , Makoto Naganuma
Recent development in endoscopic imaging has led to the detection of superficial laryngopharyngeal carcinomas and the effectiveness of endoscopic resection for superficial pharyngeal squamous cell carcinoma have been reported. However, the en bloc and complete resection rates were not sufficient. To identify the precise incision and dissection lines, ensuring a clear operating view is important. Although underwater condition during dissection is useful, saliva, bleeding, and produced floating matter make the operating view worse as the dissection process continues. We presented new method; continuous water perfusion method (CWPM) may contribute to ensuring a clear operating view during dissection of endoscopic resection for superficial pharyngeal squamous cell carcinomas.
内镜成像的最新发展已经导致浅表喉咽癌的检测和内镜切除浅表咽鳞状细胞癌的有效性已被报道。然而,整体和完全切除率是不够的。为了确定精确的切口和剥离线,确保清晰的手术视野是重要的。虽然水下条件在解剖过程中是有用的,但随着解剖过程的继续,唾液、出血和产生的漂浮物会使手术效果变差。我们提出了新的方法;连续水灌注法(CWPM)有助于确保内镜下咽浅表鳞状细胞癌切除术夹层的手术视野清晰。
{"title":"New method; continuous water perfusion method during endoscopic resection for the superficial pharyngeal squamous cell carcinoma","authors":"Naohiro Nakamura ,&nbsp;Tomofumi Sakagami ,&nbsp;Kensuke Suzuki ,&nbsp;Takuo Fujisawa ,&nbsp;Takuya Shijimaya ,&nbsp;Sanshiro Kobayashi ,&nbsp;Masataka Masuda ,&nbsp;Yu Takahashi ,&nbsp;Tomomitsu Tahara ,&nbsp;Makoto Naganuma","doi":"10.1016/j.anl.2025.10.002","DOIUrl":"10.1016/j.anl.2025.10.002","url":null,"abstract":"<div><div>Recent development in endoscopic imaging has led to the detection of superficial laryngopharyngeal carcinomas and the effectiveness of endoscopic resection for superficial pharyngeal squamous cell carcinoma have been reported. However, the en bloc and complete resection rates were not sufficient. To identify the precise incision and dissection lines, ensuring a clear operating view is important. Although underwater condition during dissection is useful, saliva, bleeding, and produced floating matter make the operating view worse as the dissection process continues. We presented new method; continuous water perfusion method (CWPM) may contribute to ensuring a clear operating view during dissection of endoscopic resection for superficial pharyngeal squamous cell carcinomas.</div></div>","PeriodicalId":55627,"journal":{"name":"Auris Nasus Larynx","volume":"52 6","pages":"Pages 687-689"},"PeriodicalIF":1.5,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145318745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishing a comprehensive national auditory implant registry in Japan: Trends and demographics from the first two years (2023–2024) 在日本建立一个全面的国家听觉植入注册:前两年(2023-2024)的趋势和人口统计数据。
IF 1.5 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-10-17 DOI: 10.1016/j.anl.2025.09.009
Ayu Akazawa , Takeshi Fujita , Kensuke Uraguchi , Megumi Kitayama , Taku Ito , Yasuhiro Osaki , Kyoko Shirai , Haruo Yoshida , Norio Yamamoto , Katsumi Doi , Satoshi Iwasaki , Naoki Oishi

Objective

To describe the establishment and initial findings of Japan’s first comprehensive nationwide registry covering cochlear implants (CIs), active middle ear implants (AMEIs), and bone conduction implants (BCIs), launched in 2023. The registry aims to improve national data collection, support evidence-based policymaking, and track trends in surgical practice and patient demographics.

Methods

A web-based electronic data capture (EDC) system was implemented to replace the previous paper-based reporting system. Between January 2023 and December 2024, data were voluntarily submitted by participating facilities across Japan. Collected data included patient demographics, implant types, hearing thresholds, etiologies, and manufacturer information. Registry completeness was assessed by comparison with Japan’s National Database of Health Insurance Claims (NDB).

Results

A total of 1880 patients were registered, and 1809 patients with surgical information entered from 104 facilities were selected for analysis, comprising 1723 CI cases and 86 AMEI or BCI cases (11 VSB, 22 BB, 53 Baha). Among 605 pediatric CI recipients, early-age implantation was increasingly observed, with 58 patients (10 %) aged under 1 year and 183 (30 %) aged 1 year. Among adult CI recipients, 271 patients were aged 75 years or older, including 40 patients aged 85 years or older. Additionally, simultaneous bilateral CI surgery was performed in 265 patients, of whom 175 were children, reflecting the expanding indications. Patients with better ear thresholds <90 dB HL accounted for 33 % of adults and 29 % of children. Congenital hearing loss predominated in children, while acquired causes were more common in adults. Among cases with a known etiology, hereditary deafness was the most common (24.5 %), although 39.6 % of etiologies were unknown. CI data completeness reached 73 % compared with NDB, indicating strong nationwide participation and a high level of data reliability.

Conclusion

This is the first comprehensive report from the national registry in Japan that includes not only CIs but also AMEIs and BCIs. The registry demonstrated reliable data capture and highlighted important trends in patient demographics and surgical practices. Continued data collection will enhance clinical decision-making and support policy development, ultimately improving care for auditory implant recipients.
目的:描述日本第一个涵盖人工耳蜗(CIs)、主动中耳植入物(AMEIs)和骨传导植入物(bci)的全面全国注册系统的建立和初步发现,该系统将于2023年启动。该登记处旨在改善国家数据收集,支持基于证据的政策制定,并跟踪外科实践和患者人口统计的趋势。方法:采用基于网络的电子数据采集(EDC)系统取代以往的纸质报告系统。在2023年1月至2024年12月期间,日本各地的参与设施自愿提交了数据。收集的数据包括患者人口统计、植入物类型、听力阈值、病因和制造商信息。通过与日本国家健康保险索赔数据库(NDB)的比较来评估登记完整性。结果:共登记1880例患者,选取104家医院输入的1809例手术信息进行分析,其中CI 1723例,AMEI或BCI 86例(VSB 11例,BB 22例,Baha 53例)。在605例儿童CI受者中,越来越多地观察到早期植入,其中58例(10%)患者年龄在1岁以下,183例(30%)患者年龄在1岁。在成人CI接受者中,271例患者年龄在75岁及以上,其中40例患者年龄在85岁及以上。此外,265例患者同时进行了双侧CI手术,其中175例为儿童,反映了适应症的扩大。结论:这是日本国家登记的第一份综合报告,不仅包括ci,还包括amei和bci。该登记处展示了可靠的数据捕获,并突出了患者人口统计和手术实践的重要趋势。持续的数据收集将加强临床决策和支持政策的制定,最终改善听觉植入接受者的护理。
{"title":"Establishing a comprehensive national auditory implant registry in Japan: Trends and demographics from the first two years (2023–2024)","authors":"Ayu Akazawa ,&nbsp;Takeshi Fujita ,&nbsp;Kensuke Uraguchi ,&nbsp;Megumi Kitayama ,&nbsp;Taku Ito ,&nbsp;Yasuhiro Osaki ,&nbsp;Kyoko Shirai ,&nbsp;Haruo Yoshida ,&nbsp;Norio Yamamoto ,&nbsp;Katsumi Doi ,&nbsp;Satoshi Iwasaki ,&nbsp;Naoki Oishi","doi":"10.1016/j.anl.2025.09.009","DOIUrl":"10.1016/j.anl.2025.09.009","url":null,"abstract":"<div><h3>Objective</h3><div>To describe the establishment and initial findings of Japan’s first comprehensive nationwide registry covering cochlear implants (CIs), active middle ear implants (AMEIs), and bone conduction implants (BCIs), launched in 2023. The registry aims to improve national data collection, support evidence-based policymaking, and track trends in surgical practice and patient demographics.</div></div><div><h3>Methods</h3><div>A web-based electronic data capture (EDC) system was implemented to replace the previous paper-based reporting system. Between January 2023 and December 2024, data were voluntarily submitted by participating facilities across Japan. Collected data included patient demographics, implant types, hearing thresholds, etiologies, and manufacturer information. Registry completeness was assessed by comparison with Japan’s National Database of Health Insurance Claims (NDB).</div></div><div><h3>Results</h3><div>A total of 1880 patients were registered, and 1809 patients with surgical information entered from 104 facilities were selected for analysis, comprising 1723 CI cases and 86 AMEI or BCI cases (11 VSB, 22 BB, 53 Baha). Among 605 pediatric CI recipients, early-age implantation was increasingly observed, with 58 patients (10 %) aged under 1 year and 183 (30 %) aged 1 year. Among adult CI recipients, 271 patients were aged 75 years or older, including 40 patients aged 85 years or older. Additionally, simultaneous bilateral CI surgery was performed in 265 patients, of whom 175 were children, reflecting the expanding indications. Patients with better ear thresholds &lt;90 dB HL accounted for 33 % of adults and 29 % of children. Congenital hearing loss predominated in children, while acquired causes were more common in adults. Among cases with a known etiology, hereditary deafness was the most common (24.5 %), although 39.6 % of etiologies were unknown. CI data completeness reached 73 % compared with NDB, indicating strong nationwide participation and a high level of data reliability.</div></div><div><h3>Conclusion</h3><div>This is the first comprehensive report from the national registry in Japan that includes not only CIs but also AMEIs and BCIs. The registry demonstrated reliable data capture and highlighted important trends in patient demographics and surgical practices. Continued data collection will enhance clinical decision-making and support policy development, ultimately improving care for auditory implant recipients.</div></div>","PeriodicalId":55627,"journal":{"name":"Auris Nasus Larynx","volume":"52 6","pages":"Pages 679-686"},"PeriodicalIF":1.5,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145318778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical features of cochlear implantation in Japan and factors affecting postoperative infection 日本人工耳蜗植入术的临床特点及术后感染的影响因素。
IF 1.5 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-10-07 DOI: 10.1016/j.anl.2025.09.001
Megumi Koizumi , Akinori Kashio , Miho Ishimaru , Hiroki Matsui , Kiyohide Fushimi , Hideo Yasunaga , Tatsuya Yamasoba

Objective

This study aimed to evaluate the clinical features in a large cohort of patients who underwent cochlear implantation in Japan, including the number of simultaneous bilateral cochlear implantation, proportion of postoperative infectious complications, and factors associated with postoperative infectious complications.

Methods

This retrospective cohort study extracted data of 7893 patients who underwent 9427 cochlear implantations from a Japanese national inpatient database between July 2010 and March 2021. We determined the number of cochlear implantations, patient age, number of simultaneous bilateral surgeries, and incidence of infectious complications. The factors associated with postoperative infection were analyzed using a multivariate logistic regression model.

Results

Pediatric cases were predominant until 2016, whereas adult cases surpassed pediatric cases beginning in 2017. The proportion of patients aged > 1 year and 6 months decreased gradually since 2014. The number of simultaneous cochlear implantations increased steadily since 2016. The incidence of postoperative infection was 4.8 %. Postoperative infectious complications were significantly associated with age < 2 years at surgery, inner ear malformations, and medium hospital volumes in pediatric patients. In adults, chronic otitis media and comorbid diabetes mellitus without complications were associated with postoperative infectious complications.

Conclusions

The trends in patient age and the number of simultaneous surgeries in Japan are consistent with the revised guidelines. The incidence of postoperative infections was 4.8 %. The factors associated with postoperative infection differed between pediatric and adult patients. These findings may help surgeons in the management of cochlear implantation.
目的:本研究旨在评价日本大队列人工耳蜗植入术患者的临床特点,包括同期双侧人工耳蜗植入术次数、术后感染并发症比例及术后感染并发症相关因素。方法:本回顾性队列研究从2010年7月至2021年3月期间日本国家住院患者数据库中提取了9427例人工耳蜗植入的7893例患者的数据。我们确定了人工耳蜗植入的数量、患者年龄、同时双侧手术的数量和感染并发症的发生率。采用多因素logistic回归模型对术后感染相关因素进行分析。结果:到2016年,儿童病例占主导地位,而成人病例从2017年开始超过儿童病例。从2014年开始,年龄在bb0 ~ 1岁零6个月的患者比例逐渐下降。自2016年以来,同期人工耳蜗数量稳步增长。术后感染发生率为4.8%。小儿患者术后感染并发症与手术年龄< 2岁、内耳畸形和中等医院容量显著相关。在成人中,无并发症的慢性中耳炎和合并症糖尿病与术后感染并发症相关。结论:日本患者年龄和同时手术数量的趋势与修订后的指南一致。术后感染发生率为4.8%。儿童和成人患者术后感染的相关因素有所不同。这些发现可能有助于外科医生处理人工耳蜗植入。
{"title":"Clinical features of cochlear implantation in Japan and factors affecting postoperative infection","authors":"Megumi Koizumi ,&nbsp;Akinori Kashio ,&nbsp;Miho Ishimaru ,&nbsp;Hiroki Matsui ,&nbsp;Kiyohide Fushimi ,&nbsp;Hideo Yasunaga ,&nbsp;Tatsuya Yamasoba","doi":"10.1016/j.anl.2025.09.001","DOIUrl":"10.1016/j.anl.2025.09.001","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to evaluate the clinical features in a large cohort of patients who underwent cochlear implantation in Japan, including the number of simultaneous bilateral cochlear implantation, proportion of postoperative infectious complications, and factors associated with postoperative infectious complications.</div></div><div><h3>Methods</h3><div>This retrospective cohort study extracted data of 7893 patients who underwent 9427 cochlear implantations from a Japanese national inpatient database between July 2010 and March 2021. We determined the number of cochlear implantations, patient age, number of simultaneous bilateral surgeries, and incidence of infectious complications. The factors associated with postoperative infection were analyzed using a multivariate logistic regression model.</div></div><div><h3>Results</h3><div>Pediatric cases were predominant until 2016, whereas adult cases surpassed pediatric cases beginning in 2017. The proportion of patients aged &gt; 1 year and 6 months decreased gradually since 2014. The number of simultaneous cochlear implantations increased steadily since 2016. The incidence of postoperative infection was 4.8 %. Postoperative infectious complications were significantly associated with age &lt; 2 years at surgery, inner ear malformations, and medium hospital volumes in pediatric patients. In adults, chronic otitis media and comorbid diabetes mellitus without complications were associated with postoperative infectious complications.</div></div><div><h3>Conclusions</h3><div>The trends in patient age and the number of simultaneous surgeries in Japan are consistent with the revised guidelines. The incidence of postoperative infections was 4.8 %. The factors associated with postoperative infection differed between pediatric and adult patients. These findings may help surgeons in the management of cochlear implantation.</div></div>","PeriodicalId":55627,"journal":{"name":"Auris Nasus Larynx","volume":"52 6","pages":"Pages 672-678"},"PeriodicalIF":1.5,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145253777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Auris Nasus Larynx
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1